The Horizon Kinetics Medical ETF seeks long-term growth of capital by investing primarily in patented first line pharmaceuticals and biologics, aiming to capture returns from intrinsic valuation realization and scientific discovery.
Horizon Kinetics Medical ETF · Issued by Horizon Kinetics
| LLY | Eli Lilly and Co | 17.97% |
| ABBV | AbbVie Inc | 9.11% |
| NVS | Novartis AG ADR | 6.75% |
| JNJ | Johnson & Johnson | 5.91% |
| ALKS | Alkermes PLC | 5.01% |
| AMGN | Amgen Inc | 4.69% |
| BMY | Bristol-Myers Squibb Co | 4.67% |
| MRK | Merck & Co Inc | 4.59% |
| AZN.L | AstraZeneca PLC | 4.30% |
| IONS | Ionis Pharmaceuticals Inc | 3.48% |
No recent news for MEDX. The ingest cron pulls every 15 minutes during market hours.